Sign in

Trial result ·

Efficacy of topical polypeptide gel in accelerating early healing of diabetic ulcers: a randomized controlled trial.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This study tested a gel put on diabetic foot ulcers. The gel holds small protein pieces called polypeptides. In all, 26 people with these ulcers took part. They were put into groups by chance. One group got the polypeptide gel. The other group got a hydrocolloid gel. Neither the people nor the researchers knew who got which gel. The team checked wound size on days 7, 14 and 21.

What they found

Wounds shrank more in the polypeptide gel group on day 7. The same was true on day 14. On day 21, the gap in actual wound size was not clear. That gap could have been due to chance. The team also judged shrinking against each wound's starting size. By that measure, the polypeptide gel did better at every time point. This included day 21. The authors said these effects were large.

What it means for patients

The authors say the polypeptide gel was linked to more wound shrinking. They compared it with hydrocolloid gel. In their view, the gel kept its healing lead through the study. The study only looked at early healing, up to day 21.

Why it is not certain yet

Only 26 people took part. People were followed for just 21 days. On day 21, one measure showed no clear gap between the gels. The abstract does not say how many wounds fully healed. It also does not report any side effects. Larger and longer studies would help confirm these results.

Source

Efficacy of topical polypeptide gel in accelerating early healing of diabetic ulcers: a randomized controlled trial.

PubMed · PMID 42809760

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Diabetic foot ulcer publications